The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective Study.

about

The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective Study.

Item

http://www.wikidata.org/entity/Q36242803

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The Impact of the Duration of ...... ancer - A Retrospective Study.

@ast

The Impact of the Duration of ...... ancer - A Retrospective Study.

@en

type

Item

label

The Impact of the Duration of ...... ancer - A Retrospective Study.

@ast

The Impact of the Duration of ...... ancer - A Retrospective Study.

@en

prefLabel

The Impact of the Duration of ...... ancer - A Retrospective Study.

@ast

The Impact of the Duration of ...... ancer - A Retrospective Study.

@en

P1476

The Impact of the Duration of ...... ancer - A Retrospective Study.

@en

P2093

Alexander Reinthaller

http://www.w3.org/2001/XMLSchema#string

Heinz Koelbl

http://www.w3.org/2001/XMLSchema#string

Nicole Concin

http://www.w3.org/2001/XMLSchema#string

Regina Nehoda

http://www.w3.org/2001/XMLSchema#string

Stephan Polterauer

http://www.w3.org/2001/XMLSchema#string

Veronika Seebacher

http://www.w3.org/2001/XMLSchema#string

P2860

The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years

Chemotherapy dose reduction and delay in clinical practice. evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

Prognostic significance of the relative dose intensity of chemotherapy in primary treatment of epithelial ovarian cancer.

Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.

Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.

P304

e0169272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0169272

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28060918

http://www.w3.org/2001/XMLSchema#string

P932

5218558

http://www.w3.org/2001/XMLSchema#string